6.55 USD
↗ 0.29 (4.55%)AT CLOSE (11:59 AM EDT)
Cartesian Therapeutics, Inc. Common Stock
RNACNASDAQ • USD
6.61
↗ 0.06 (0.92%)
POST MARKET (AS OF 06:26 PM EDT)
Post Market
AS OF 06:26 PM EDT
6.61
↗ 0.06 (0.92%)
Market: CLOSED
Open?$6.32
High?$6.97
Low?$6.32
Prev. Close?$6.27
Volume?87.5K
Avg. Volume?171.7K
VWAP?$6.62
Rel. Volume?0.51x
Bid / Ask
Bid?$6.38 × 3.0K
Ask?$6.90 × 100
Spread?$0.52
Midpoint?$6.64
Valuation & Ratios
Market Cap?192.4M
Shares Out?29.4M
Float?12.1M
Float %?41.0%
P/E Ratio?N/A
P/B Ratio?-1.30
EPS?-$5.26
Dividend?0.00%
Ex-Dividend?N/A
Cartesian Therapeutics, Inc. Common Stock (RNAC) trades at $6.56 per share. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (104.2%) and a bearish Death Cross on the long-term moving averages. On the valuation front, RNAC trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Jun 4, 2026.
News
Profile
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Themes
Employees
75
Market Cap
184.1M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2016-06-22
Address
7495 NEW HORIZON WAY
FREDERICK, MD 21703
Phone: 301-348-8698
FREDERICK, MD 21703
Phone: 301-348-8698
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?19
Piotroski F-Score?0/9Weak
Altman Z-Score?-5.16Distress
Confidence?68%Moderate
Short InterestVery High
Short % of Float?18.38%High
Short Interest?2.2M
Days to Cover?11.9
Free Float12.1M
Avg Daily Volume186.6K
Settlement Date2026-05-15
Financial Health
Current Ratio?7.65Strong
Quick Ratio?7.65Strong
Cash Ratio?7.44Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-1.30CHEAP▾
S&P97
P/S?108.42HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-0.8CHEAP▾
S&P97
EV/Sales?41.58HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?104.2%STRONG▾
Peers50
S&P97
ROA?-53.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-77374000
Enterprise Value?$73.8M
Fundamentals ratios updated end of day